| Company Name: | UnitedHealth Group Inc | | Ticker Symbol: | UNH | | CIK Number: | 0000731766 | | WWW Address: | http://www.unitedhealthgroup.com |
| CEO: | David S. Wichmann | | No. of Employees: | 230,000 |
| Common Issue Type: | CS | | Business Description: | UnitedHealth Group, Inc. designs products, provides services and applies technologies that improve access to health and well-being services, simplify the health care experience and make health care more affordable.
|
| | | Industry Information: | HEALTH SERVICES - Health Care Plans [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 271.11 |  0.0 | - | - | | 265.33 | 255.93 | 139 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 260,936.2 | 962.5 | 0.00 | 10.95 | 3.60 | 24.1 | 1.3 | 272.81 - 207.07 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 256.38 | $ | | PE Ratio - LTM | 24.1 | |
| Market Capitalisation | 260,936.2 | mil |
| Latest Shares Outstanding | 962.5 | mil |
| Earnings pS (EPS) | 10.95 | $ |
| Dividend pS (DPS) | 3.60 | ¢ |
| Dividend Yield | 1.3 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 831,714 | $ |
| Effective Tax Rate | 35.9 | % |
| Float | 954.9 | mil |
| Float as % of Shares Outstanding | 1.0 | % |
| Foreign Sales | - | |
| Domestic Sales | - | |
| Selling, General & Adm/tive (SG&A) as % of Revenue | - | |
| Research & Devlopment (R&D) as % of Revenue | - | |
| Gross Profit Margin | - | |
| EBITDA Margin | 8.7 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 153.6 | % |
| Return on Assets (ROA) | 8.1 | % |
| Return on Equity (ROE) | 24.5 | % |
| Return on Capital Invested (ROCI) | 15.2 | % |
| Current Ratio | - | |
| Leverage Ratio (Assets/Equity) | 2.9 | |
| Interest Cover | 12.8 | |
| Total Debt/Equity (Gearing Ratio) | 0.66 | |
| LT Debt/Total Capital | 38.0 | % |
| Working Capital pS | - | |
| Cash pS | - | |
| Book-Value pS | 50.18 | $ |
| Tangible Book-Value pS | -15.86 | $ |
| Cash Flow pS | 17.57 | $ |
| Free Cash Flow pS | 15.49 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 5.15 | |
| Price/Tangible Book Ratio | 0.00 | |
| Price/Cash Flow | 14.7 | |
| Price/Free Cash Flow | 16.7 | |
| P/E as % of Industry Group | 58.0 | % |
| P/E as % of Sector Segment | 80.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 3.60 |
| Current Dividend Yield | 1.3 |
| 5-Y Average Dividend Yield | 0.9 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 8.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.9 | 5 | 3,493,138 | 10,508,693 |
| 4 Weeks | 272.81 | 255.78 | 264.82 | 0.0 | 9 | 2,843,425 | 51,181,654 |
| 13 Weeks | 272.81 | 252.23 | 254.93 | 3.9 | 11 | 2,147,464 | 133,142,822 |
| 26 Weeks | 272.81 | 228.23 | 234.90 | 12.8 | 12 | 2,113,044 | 264,130,567 |
| 52 Weeks | 272.81 | 207.07 | 207.58 | 27.6 | 24 | 2,462,795 | 613,236,047 |
| YTD | 272.81 | 208.48 | - | 19.8 | 21 | 2,544,667 | 516,567,547 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 263.08 | 263.12 | 265.07 | 251.21 | 245.03 | 0.00 | 0.00 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 0.13 | 0.3 | 0.16 |
| Income | 0.14 | 0.5 | 0.23 |
| Dividend | 0.29 | 0.6 | 0.27 |
| Capital Spending | 0.14 | NA | 0.19 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 11.2 | 11.2 | 8.6 |
| Earnings % | -10.7 | -10.7 | 7.5 |
| EPS % | -11.5 | -11.5 | 11.6 |
| EPS $ | -0.15 | -0.15 | 0.55 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| |
| |
| |
| |
| FINANCIAL STRUCTURE RATIOS |
| Financial Leverage Ratio (Assets/Equity) | 2.91 |
| Debt Ratio | 65.64 |
| Total Debt/Equity (Gearing Ratio) | 0.66 |
| LT Debt/Equity | 0.60 |
| LT Debt/Capital Invested | 37.64 |
| LT Debt/Total Liabilities | 31.59 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.00 |
| Tobin's Q Ratio | 1.90 |
| Current P/E Ratio - LTM | 24.10 |
| Enterprise Value (EV)/EBITDA | 0.14 |
| Enterprise Value (EV)/Free Cash Flow | 38.43 |
| Dividend Yield | 1.3 |
| Price/Tangible Book Ratio - LTM | 0.00 |
| Price/Book Ratio - LTM | 5.15 |
| Price/Cash Flow Ratio | 14.7 |
| Price/Free Cash Flow Ratio - LTM | 16.7 |
| P/E Ratio (1 month ago) - LTM | 12.2 |
| P/E Ratio (26 weeks ago) - LTM | 10.3 |
| P/E Ratio (52 weeks ago) - LTM | 12.2 |
| 5-Y High P/E Ratio | 22.7 |
| 5-Y Low P/E Ratio | 5.6 |
| 5-Y Average P/E Ratio | 10.1 |
| Current P/E Ratio as % of 5-Y Average P/E | 52 |
| P/E as % of Industry Group | 58.0 |
| P/E as % of Sector Segment | 80.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 12.5 |
| PER SHARE FIGURES |
| Tangible Book Value pS - LTM | -15.86 |
| Book Value pS - LTM | 50.18 |
| Capital Invested pS | 79.60 |
| Cash Flow pS - LTM | 17.57 |
| Free Cash Flow pS - LTM | 15.49 |
| Earnings pS (EPS) | 10.95 |
| | | | OPERATING RATIOS | | PROFITABILITY |
| Return on Equity (ROE) | 22.10 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.2 |
| Return on Capital Invested (ROCI) | 13.29 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 0.1 |
| Return on Assets (ROA) | 7.59 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.1 |
| EBIT Margin - LTM | 7.6 |
| EBITDA Margin - LTM | 8.7 |
| |
| |
| |
| |
| |
| |
| EFFICIENCY RATIOS |
| Revenue per Employee - LTM | 854,707 |
| Net Income per Employee - LTM | 40,436 |
| Assets/Revenue - LTM | 18.52 |
| |
|
|  
| | |  |  | | |
